MicrobiologybioRxiv
Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro
K. Shionoya, M. Yamasaki, S. Iwanami…·K. Watashi
This study identifies Mefloquine as a potent in vitro entry inhibitor of SARS-CoV-2 with higher antiviral activity than Hydroxychloroquine.
DOI 10.3389/fmicb.2021.651403